Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen IncfiledCriticalAmgen Inc
Publication of AR121799A2publicationCriticalpatent/AR121799A2/en
Se proporcionan proteínas de unión a antígenos que se unen a la proteína de IL-23 humana. Asimismo, se proporcionan ácidos nucleicos que codifican la proteína de unión al antígeno, vectores, y células que la codifican así como el uso de proteínas de unión a antígenos de IL-23 con fines de diagnóstico y terapéuticos.Antigen binding proteins that bind to the human IL-23 protein are provided. Also provided are nucleic acids encoding antigen-binding protein, vectors, and cells encoding it as well as the use of IL-23 antigen-binding proteins for diagnostic and therapeutic purposes.
ARP210100934A2009-10-262021-04-08
HUMAN IL-23 ANTIGEN-BINDING PROTEINS
AR121799A2
(en)
Humanized antibody that binds to the human il-7 receptor alpha chain (cd127); antigen binding protein comprising one or more complementarity determining regions of said antibody; nucleic acid molecule encoding an antibody or enhancement protein; expression vector, recombinant host cell; procedure for the production of an antigen binding protein; procedure to treat autoimmune or inflammatory disease.